These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25027866

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

  • 44. Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
    Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, Pang VF, Liu RS, Lin WJ, Yang CS, Ting G.
    J Nucl Med; 2009 Dec 02; 50(12):2073-81. PubMed ID: 19949027
    [Abstract] [Full Text] [Related]

  • 45. Development of in situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinoma.
    Peng CL, Shih YH, Liang KS, Chiang PF, Yeh CH, Tang IC, Yao CJ, Lee SY, Luo TY, Shieh MJ.
    Mol Pharm; 2013 May 06; 10(5):1854-64. PubMed ID: 23485019
    [Abstract] [Full Text] [Related]

  • 46. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
    Hsu CW, Chang YJ, Chang CH, Chen LC, Lan KL, Ting G, Lee TW.
    Cancer Biother Radiopharm; 2012 Oct 06; 27(8):481-9. PubMed ID: 23067100
    [Abstract] [Full Text] [Related]

  • 47. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
    Burade V, Bhowmick S, Maiti K, Zalawadia R, Ruan H, Thennati R.
    BMC Cancer; 2017 Jun 06; 17(1):405. PubMed ID: 28587612
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
    Yoshizawa Y, Kono Y, Ogawara K, Kimura T, Higaki K.
    Int J Pharm; 2011 Jun 30; 412(1-2):132-41. PubMed ID: 21507344
    [Abstract] [Full Text] [Related]

  • 51. Antennapedia-derived positively-charged peptide faces multiple problems upon their usage as targeting ligand for liposomal doxorubicin.
    Kousani S, Karimi M, Teymouri M, Navashenaq JG, Darban SA, Jaafari MR.
    Biotechnol Prog; 2021 Nov 30; 37(6):e3202. PubMed ID: 34405574
    [Abstract] [Full Text] [Related]

  • 52. Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin.
    Song H, Zhang J, Han Z, Zhang X, Li Z, Zhang L, Fu M, Lin C, Ma J.
    Cancer Chemother Pharmacol; 2006 May 30; 57(5):591-8. PubMed ID: 16133530
    [Abstract] [Full Text] [Related]

  • 53. 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells.
    Moosavian SA, Abnous K, Akhtari J, Arabi L, Gholamzade Dewin A, Jafari M.
    Artif Cells Nanomed Biotechnol; 2018 Dec 30; 46(8):2054-2065. PubMed ID: 29205059
    [Abstract] [Full Text] [Related]

  • 54. External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics.
    Chang CH, Liu SY, Chi CW, Yu HL, Chang TJ, Tsai TH, Lee TW, Chen YJ.
    Int J Nanomedicine; 2015 Dec 30; 10():3641-9. PubMed ID: 26056445
    [Abstract] [Full Text] [Related]

  • 55. Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model.
    Chang YJ, Hsu CW, Chang CH, Lan KL, Ting G, Lee TW.
    Invest New Drugs; 2013 Aug 30; 31(4):801-11. PubMed ID: 23224353
    [Abstract] [Full Text] [Related]

  • 56. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
    He J, Liu C, Vanderheyden JL, Liu G, Dou S, Rusckowski M, Hnatowich DJ.
    Nucl Med Commun; 2004 Jul 30; 25(7):731-6. PubMed ID: 15208502
    [Abstract] [Full Text] [Related]

  • 57. Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors.
    Ogawara K, Un K, Minato K, Tanaka K, Higaki K, Kimura T.
    Int J Pharm; 2008 Jul 09; 359(1-2):234-40. PubMed ID: 18448289
    [Abstract] [Full Text] [Related]

  • 58. Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.
    Wu SK, Chiang CF, Hsu YH, Lin TH, Liou HC, Fu WM, Lin WL.
    Int J Nanomedicine; 2014 Jul 09; 9():4485-94. PubMed ID: 25278753
    [Abstract] [Full Text] [Related]

  • 59. Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma.
    Shahraki N, Mehrabian A, Amiri-Darban S, Moosavian SA, Jaafari MR.
    Colloids Surf B Biointerfaces; 2021 Apr 09; 200():111589. PubMed ID: 33545570
    [Abstract] [Full Text] [Related]

  • 60. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
    Bao A, Goins B, Klipper R, Negrete G, Phillips WT.
    J Nucl Med; 2003 Dec 09; 44(12):1992-9. PubMed ID: 14660726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.